-
25浏览
-
0点赞
-
0收藏
-
0分享
-
89下载
-
0评论
-
引用
期刊论文
Expression of HIF-2a/EPASl in hepatocellular carcinoma
,-0001,():
AIM: To investigate the expression of hypoxia-inducible factor (HIF)-2a/endothelial PAS domain protein 1 (EPAS1) in hepatocellular carcinoma (HCC). METHODS: Expression of HIF-2a/EPASl was investigated immunohistochemically on paraffin-embedded sections from 97 patients with HCC. To further confirm that HIF-2a/EPASl in HCC tissues also correlated with angiogenesis, a parallel immunohistchemistry study of vascular endothelial growth factor (VEGF) was performed on these 97 cases. RESULTS: HIF-2a/EPASl could be detected in 50 of 97 cases (51.6%), including 19 weakly positive (19.8%), and 31 strongly positive (31.1%), the other 47 cases were negative (48.4%). The expression of HIF-2a/EPASlwas significantly correlated with tumor size, capsule infiltration, portal vein invasion, and necrosis. A parallel immunohistochemical analysis of VEGF demonstrated its positive correlation with capsule infiltration, portal vein invasion, and HIF-2a/EPASl overexpression, which supported the correlation of HIF-2a/EPASlup-regulation with tumor angiogenesis. No apparent correlation was observed between HIF-2a/EPASl and capsular formation, presence of cirrhosis, and histological grade. CONCLUSION: HIF-2a/EPASl is expressed in most of HCC with capsular infiltration and portal vein invasion, which indicates a possible role of HIF-2a/EPASl in HCC metastasis.
【免责声明】以下全部内容由[杨连粤]上传于[2005年08月06日 00时24分46秒],版权归原创者所有。本文仅代表作者本人观点,与本网站无关。本网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。
本学者其他成果
同领域成果